Q&A of Metabolomics Experimental Scheme

What samples can be detected by metabolomics?

A: Metabolomics focuses on small molecule metabolites (MW<1000) as substrates and products of various metabolic pathways. The samples that can be assayed are mainly urine, plasma or serum, saliva, and cell and tissue extracts. We have also done plant, fungal, and microbial extracts, cerebrospinal fluid, lymphatic fluid, insect hemolymph, amniotic fluid, follicular fluid, knee synovial fluid, tears, semen, fecal and intestinal contents extracts, etc.

Do I need to set up biological replicates for metabolomics? How many biological replicates should be set up?

A: Compared with genes and proteins, metabolites are in the downstream of life activities and have high dynamic fluctuations. Therefore, it is necessary to set up many biological replicates to increase the reliability and persuasiveness of the data in order to reduce individual differences.

For example, 6-8 replicates can be used for plants and microorganisms, and 10 or more replicates for animals. However, the clinical requirements are much higher, as individual differences in humans are so great that 30 or more biological replicates are generally recommended.

What is the lowest level of metabolites that can be detected by metabolomics?

A: Different detection platforms have different sensitivities. LC-MS has the highest sensitivity, which can reach fM level. The ionization efficiency and signal response intensity of mass spectrometry can vary greatly for different substances with the same content due to their own chemical properties. The detection sensitivity of a substance is related to its own chemical properties. The influence of chemical properties is mainly expressed in the ionization efficiency and mass spectrometry fragmentation behavior. Therefore, different substances with the same content may be detected by one and not the other.

If the final number of samples collected from the two groups is not the same, is it okay to compare the two groups in this way?

A: Yes. It is more important that the number of biological replicates in each group is sufficiently high than the comparative analysis of the two groups.

Can the same batch of untargeted metabolomics samples be tested in batches across a longer period of time?

A: Yes, but batches spanning more than two weeks are not recommended. This is because the response of the instrument will vary somewhat from time to time, and the peak area of the same amount of substance tested at different times is different. Untargeted metabolomics analysis calculates the content change multiplication based on the peak area. Detection in two or more batches can lead to large errors in the calculation results.

* For Research Use Only. Not for use in diagnostic procedures.

Our customer service representatives are available 24 hours a day, 7 days a week. Inquiry

From Our Clients

"I recently used their proteomics service for a project analyzing protein interactions in yeast models. The team was very responsive and helped clarify the methodology they employed, which made me feel confident in the results. The data quality was solid, with clear identification of several key proteins involved in our study. Their thorough analysis enabled me to pinpoint specific interactions that I hadn't considered before, which significantly improved the direction of my research. I appreciate their professionalism and support throughout the process."

Sarah Thompson, University of California, Berkeley

"Our lab collaborated with them on a project studying cancer biomarkers. The proteomics analysis provided was detailed and focused, specifically highlighting the differential expression of proteins between healthy and tumor samples. Their clear explanations of the data helped my team understand the biological implications. I also appreciated their willingness to revise the reports based on our feedback, ensuring that we had everything we needed for our publication. This collaborative spirit was invaluable."

Emily Rodriguez, Stanford University

"Our lab worked with them on a project studying the effects of diet on gut microbiota using proteomics. They used a label-free quantification method to analyze proteins in fecal samples before and after dietary intervention. The results showed significant changes in protein expression linked to microbial activity. This was pivotal for our hypothesis about diet-microbiota interactions. The clarity of their data presentation made it easy for our team to integrate these findings into our ongoing research."

Dr. Lisa Wong, University of Toronto

"My experience with Creative Proteomics during the mass spectrometry analysis was excellent. We sent in human saliva and mouse brain tissue samples, which they expertly analyzed using both LC-MS and GC-MS techniques. The results were invaluable, revealing key metabolites in the saliva and identifying biomarkers linked to brain function in the brain tissue."

Dr. Emily Carter, Senior Research Scientist

"The overall service from Creative Proteomics was outstanding. They made the entire process seamless and efficient, allowing us to focus on our research. We worked with leaf and root samples from various Arabidopsis genotypes for targeted metabolomics analysis. Their thorough profiling of primary and secondary metabolites gave us important insights into how the plants respond metabolically to environmental stress."

Dr. Laura Henderson, Plant Physiologist

"We had a pleasant collaboration with Creative Proteomics on mass spectrometry analysis of lipids. They conducted a detailed analysis of lipid species, providing us with important insights into lipid metabolism and its relationship with metabolic syndrome disease states."

Dr. Sarah Mitchell, Research Scientist